Buspirone Hydrochloride Tablet
Product Images NDC 0615-8527

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 0615-8527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Buspirone 8527 1)

FDA Label Image

10 mg (one-third Of A Tablet) (Buspirone 8527 10)

FDA Label Image

Break Tablet 30 mg (Buspirone 8527 11)

FDA Label Image

Principal Display Panel (Buspirone 8527 12)

This is a description of Buspirone Hydrochloride tablets with 30mg strength. The tablets are for institutional use only and are stored at 20° to 25°C. The usual dosage instructions are provided in the package insert. Lot numbers and different strengths of the tablets are listed along with manufacturer details. The package design is stated to be a trademark of Omnicare, Inc.*

FDA Label Image

15 mg (the Entire Tablet) (Buspirone 8527 2)

FDA Label Image

10 mg (two-thirds Of A Tablet) (Buspirone 8527 3)

FDA Label Image

7.5 mg (one-half Of A Tablet) (Buspirone 8527 4)

FDA Label Image

5 mg (one-third Of A Tablet) (Buspirone 8527 5)

FDA Label Image

Break Tablet 15 mg (Buspirone 8527 6)

FDA Label Image

30 mg (the Entire Tablet) (Buspirone 8527 7)

FDA Label Image

20 mg (two-thirds Of A Tablet) (Buspirone 8527 8)

FDA Label Image

15 mg (one-half Of A Tablet) (Buspirone 8527 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.